合計 50 件の最近のインサイダー取引記録が記録されています Candel Therapeutics, Inc. (CADL), 内訳は 34 件の買い および 15 件の売り. インサイダー買い総額は $26.12M インサイダー売り総額は $1.25M.
最近活動のある主要インサイダーには Papa Joseph C, Manning Paul B, Loggia Nicoletta. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — CADL
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-31 |
Papa Joseph C |
Director |
RSU 付与（制限付株式） |
2,795 |
$4.90 |
$13.7K |
2,795 |
| 2026-03-31 |
Manning Paul B |
Director |
RSU 付与（制限付株式） |
4,618 |
$4.90 |
$22.63K |
4,618 |
| 2026-03-31 |
Loggia Nicoletta |
Director |
RSU 付与（制限付株式） |
779 |
$4.90 |
$3.82K |
779 |
| 2026-02-23 |
Manning Paul B |
Director |
情報に基づく買い |
550,458 |
$5.45 |
$3M |
2,763,527 |
| 2026-01-26 |
Nichols William Garrett |
Chief Medical Officer |
RSU 付与（制限付株式） |
136,500 |
$6.01 |
$820.37K |
136,500 |
| 2026-01-26 |
Tak Paul Peter |
Chief Executive Officer |
RSU 付与（制限付株式） |
629,000 |
$6.01 |
$3.78M |
629,000 |
| 2026-01-26 |
Barone Francesca |
Chief Scientific Officer |
RSU 付与（制限付株式） |
232,000 |
$6.01 |
$1.39M |
232,000 |
| 2026-01-26 |
Tyagarajan Seshu |
Chief Technology Officer |
RSU 付与（制限付株式） |
154,000 |
$6.01 |
$925.54K |
154,000 |
| 2026-01-26 |
Schoch Charles |
Chief Financial Officer |
RSU 付与（制限付株式） |
232,000 |
$6.01 |
$1.39M |
232,000 |
| 2025-07-28 |
Nichols William Garrett |
Chief Medical Officer |
オプション行使（売却） |
937 |
$1.29 |
$1.21K |
29,377 |
| 2025-06-30 |
Nichols William Garrett |
Chief Medical Officer |
オプション行使（売却） |
781 |
$1.29 |
$1.01K |
30,314 |
| 2025-06-25 |
Papa Joseph C |
Director |
RSU 付与（制限付株式） |
64,239 |
$4.67 |
$300K |
64,239 |
| 2025-06-25 |
Manning Paul B |
Director |
RSU 付与（制限付株式） |
1,070,663 |
$4.67 |
$5M |
2,213,069 |
| 2025-06-25 |
Nabel Gary J. |
Director |
RSU 付与（制限付株式） |
5,353 |
$4.67 |
$25K |
5,353 |
| 2025-06-25 |
Martell Christopher |
Director |
RSU 付与（制限付株式） |
111,349 |
$4.67 |
$520K |
111,349 |
| 2025-06-25 |
Tak Paul Peter |
Chief Executive Officer |
RSU 付与（制限付株式） |
42,826 |
$4.67 |
$200K |
268,566 |
| 2025-06-25 |
Barone Francesca |
Chief Scientific Officer |
RSU 付与（制限付株式） |
4,282 |
$4.67 |
$20K |
100,809 |
| 2025-06-25 |
Tyagarajan Seshu |
Chief Technology Officer |
RSU 付与（制限付株式） |
5,353 |
$4.67 |
$25K |
90,865 |
| 2025-06-25 |
Loggia Nicoletta |
Director |
RSU 付与（制限付株式） |
2,141 |
$4.67 |
$10K |
2,141 |
| 2025-06-25 |
Schoch Charles |
Chief Financial Officer |
RSU 付与（制限付株式） |
5,353 |
$4.67 |
$25K |
43,391 |
| 2025-06-20 |
Schoch Charles |
Chief Financial Officer |
RSU 付与（制限付株式） |
50,000 |
$4.75 |
$237.5K |
50,000 |
| 2025-06-17 |
Papa Joseph C |
Director |
RSU 付与（制限付株式） |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Manning Paul B |
Director |
RSU 付与（制限付株式） |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Benz Edward J. Jr |
Director |
RSU 付与（制限付株式） |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Gaeta Renee |
Director |
RSU 付与（制限付株式） |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Nguyen Diem |
Director |
RSU 付与（制限付株式） |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Nabel Gary J. |
Director |
RSU 付与（制限付株式） |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Martell Christopher |
Director |
RSU 付与（制限付株式） |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Loggia Nicoletta |
Director |
RSU 付与（制限付株式） |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-04 |
Radhakrishnan Maha |
Officer |
不明 |
- |
- |
- |
- |
| 2025-06-04 |
Radhakrishnan Maha |
Director |
RSU 付与（制限付株式） |
28,480 |
$5.60 |
$159.49K |
28,480 |
| 2025-03-19 |
Tak Paul Peter |
Chief Executive Officer |
情報に基づく売り |
400 |
$9.00 |
$3.6K |
225,740 |
| 2025-03-18 |
Nichols William Garrett |
Chief Medical Officer |
オプション行使（売却） |
13,905 |
$1.29 |
$17.94K |
31,095 |
| 2025-03-18 |
Tak Paul Peter |
Chief Executive Officer |
情報に基づく売り |
25,772 |
$8.77 |
$226.02K |
226,140 |
| 2025-03-18 |
Barone Francesca |
Chief Scientific Officer |
オプション行使（売却） |
18,000 |
$1.55 |
$27.9K |
30,822 |
| 2025-03-17 |
Tyagarajan Seshu |
Chief Technology Officer |
オプション行使（売却） |
20,000 |
$1.29 |
$25.8K |
70,000 |
| 2025-03-17 |
Schoch Charles |
See Remarks |
情報に基づく売り |
5,000 |
$8.83 |
$44.17K |
38,038 |
| 2025-03-17 |
Tyagarajan Seshu |
Chief Technology Officer |
オプション行使 |
20,000 |
$1.29 |
$25.8K |
116,790 |
| 2025-02-21 |
Aguilar-cordova Estuardo |
10 Percent Owner |
株式返還 |
10,582 |
$12.02 |
$127.2K |
120,861 |
| 2025-02-12 |
Nichols William Garrett |
Chief Medical Officer |
RSU 付与（制限付株式） |
107,250 |
$8.55 |
$916.99K |
107,250 |
| 2025-02-12 |
Tak Paul Peter |
Chief Executive Officer |
RSU 付与（制限付株式） |
525,000 |
$8.55 |
$4.49M |
525,000 |
| 2025-02-12 |
Barone Francesca |
Chief Scientific Officer |
RSU 付与（制限付株式） |
115,000 |
$8.55 |
$983.25K |
115,000 |
| 2025-02-12 |
Tyagarajan Seshu |
Chief Technology Officer |
RSU 付与（制限付株式） |
65,000 |
$8.55 |
$555.75K |
65,000 |
| 2025-02-12 |
Schoch Charles |
See Remarks |
RSU 付与（制限付株式） |
83,000 |
$8.55 |
$709.65K |
83,000 |
| 2025-02-10 |
Aguilar-cordova Estuardo |
10 Percent Owner |
株式返還 |
31,335 |
$8.61 |
$269.79K |
60,000 |
| 2025-01-15 |
Nichols William Garrett |
Chief Medical Officer |
情報に基づく売り |
10,428 |
$7.23 |
$75.34K |
79,320 |
| 2025-01-15 |
Tak Paul Peter |
Chief Executive Officer |
情報に基づく売り |
21,704 |
$7.23 |
$156.81K |
251,912 |
| 2025-01-15 |
Barone Francesca |
Chief Scientific Officer |
情報に基づく売り |
13,534 |
$7.23 |
$97.78K |
110,673 |
| 2025-01-15 |
Tyagarajan Seshu |
Chief Technology Officer |
情報に基づく売り |
14,322 |
$7.23 |
$103.48K |
96,790 |
| 2025-01-15 |
Schoch Charles |
See Remarks |
情報に基づく売り |
9,511 |
$7.23 |
$68.72K |
43,038 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
